Font Size: a A A

To Study The Correlation To Chemosensitivity Tests Of Peripheral Blood Lymphocytes Of Hepatocellular Carcinoma Patients

Posted on:2012-10-04Degree:MasterType:Thesis
Country:ChinaCandidate:L TangFull Text:PDF
GTID:2214330368479322Subject:Surgery
Abstract/Summary:PDF Full Text Request
Objective: Chemosensitivity test (CST) is considered as a perfect treatment for individual chemotherapy of patients with malignant tumors, and was attempted to treat more and more tumor patients. Multi-drug resistance is one of the major causes of treatment failure of chemotherapy for hepatocellular carcinoma (HCC). Individual chemotherapy under CST becomes more important gradually. So far some problems between CST and HCC chemotherapy are still unclear: e.g. if CST can be done without tumor tissues, instead of the peripheral blood lymphocytes(PBL); can man use the CST results as a guideline for TACE treatment and how will be the effectiveness for HCC patients; whether the sensitivity of HCC will be changed during the treatment course; and if the changes are disciplinary and so on. To answer the problems mentioned above ,this study aims to further explore CST correlations between tumor cells(TC)and PBL in patients with HCC; to investigate the feasibility of using PBL for CST instead of TC for CST; to observe the changes of CST during the clinical course and understand the disciplinary of the changes. Finally to find the scientific basis of reasonable chemotherapy for HCC.Methods: This study was divided into three parts.(1) correlation of sensitivity between TC and PBL in HCC: 37 cases with HCC confirmed by pathology, blood samples were measured in the pre-operation,and the TC were collected during operation, MTT assay was used to test the sensitivity to 10 kinds of anti-cancer drugs of thses cells, the difference of sensitivity were detected by contrastive analysis.(2) Serum AFP and CA125 levels were in 30 HCC patients both before and after treatment of TACE as well as in 30 controls. (3) the changes of sensitivity of 10 chemotherapeutic drugs in different periods: CST were measured before and after chemotherapy at 1,3,6,12 month using PBL, and to guide the chemotherapy,and the difference of multiple result were detected by contrastive analysis. The data were input into computer by a trained worker and analyzed by statistic software SPSS17.0 and Excel 2003.Results: (1) The inhibitory effects were no significant difference(P>0.05 ) and positively correlated between the two(r=0.803 , P=0.005),and sensitive to the chemotherapeutic drugs OXA,DDP,EADM,5-FU,GZ, nonsensitive to VCR,MTX.(2) After TACE treatment, serum AFP and CA125 levels were dropped obviously(P<0.05).(3) 29 case were involved in our study, there were significant statistical sense between before and after chemotherapy at 1, 3,6 month and after chemotherapy at 1, 3,6,12 month correlation coefficient(P<0.05),but notsense to between before and after at 12 month and 6 ,12 month(P>0.05)for 4 times. The chemosensitivity decreases gradually with increasing times in the initial 4 times.Chemosensitivity were certain increases in later result than at 6 month except for OXA and MTX .Conclusions: (1)PBL should used to replace TC to CST with HCC.(2) It has something clinical feasibility of CST as a guideline for TACE treatment with HCC.(3)To do CST was necessary before every pre-chemotherapy,through CST to master the rules of multidrug resistance,which has an important reference value for clinical chemotherapy of HCC.
Keywords/Search Tags:chemosensitivity test, hepatocellular carcinoma, lymphocyte, MTT assay, transcatheter arterial chemoembolization
PDF Full Text Request
Related items
The Value Of IVIM And DCE-MR In Patients With Hepatocellular Carcinoma Treat With Transcatheter Arterial Chemoembolization
Application Of GSI For Display Blood-supply Artery Of Residual Lesions And Diagnosis Hypo-vascular Liver Neoplasms In Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Treatment
The Change Of Serum Cytokines Before And After Transcatheter Arterial Chemoembolization And Its Significance In Hepatocellular Carcinoma
Efficacy And Safety Of Raltitrexed-based Transcatheter Arterial Chemoembolization For Intermediate And Advanced Hepatocellular Carcinoma Through Real-world Study
The Utility Of Serum PIVKA-??AFP?AFP-L3 And Other Indicators In Efficacy Surveillance And Recurrence Prediction After Transcatheter Arterial Chemoembolization In Treating Hepatocellular Carcinoma
Patient Survival And Tumour Recurrence With Transcatheter Arterial Chemoembolization After Hepatectomy For Hepatocellular Carcinoma: A Single-center Large Case Follow-up Study
Combination Of Transcatheter Arterial Chemoembolization And Radiofrequency Ablation In Treatment Of Primary Hepatocellular Carcinoma:An Analysis Of Curative Effect
Clinical Research Of Apatinib Combined With Transcatheter Arterial Chemoembolization In Treatment Of Intermediate And Advanced Hepatocellular Carcinoma
Clinical Studies Of DC-CIK Cells Were Co-cultured With Transcatheter Hepatic Arterial Chemoembolization For Middle-late Stage Hepatocellular Carcinoma
10 Impact Of Serum Vascular Endothelial Growth Factor Receptor-2and Plasma Placenta Growth Factor On Prognosis In Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization